Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations …
Background Recommendations against prostate-specific antigen (PSA) testing in 2012 have
increased advanced-stage diagnosis and prostate cancer–specific mortality rates. Objective …
increased advanced-stage diagnosis and prostate cancer–specific mortality rates. Objective …
Magnetic nanoparticles in nanomedicine: a review of recent advances
Nanomaterials, in addition to their small size, possess unique physicochemical properties
that differ from bulk materials, making them ideal for a host of novel applications. Magnetic …
that differ from bulk materials, making them ideal for a host of novel applications. Magnetic …
[HTML][HTML] Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Background Men with high serum prostate specific antigen usually undergo transrectal
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects …
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects …
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
FJH Drost, DF Osses, D Nieboer… - Cochrane Database …, 2019 - cochranelibrary.com
Background Multiparametric magnetic resonance imaging (MRI), with or without MRI‐
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, J Bellmunt, M Bolla, E Briers… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …
Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane …
FJH Drost, D Osses, D Nieboer, CH Bangma… - European urology, 2020 - Elsevier
Context Magnetic resonance imaging (MRI), with or without MRI-targeted biopsy (MRI
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …
Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use
Rapid technical advances have enabled multiparametric magnetic resonance imaging
(mpMRI) combined with magnetic resonance (MR)–targeted biopsy to become valuable …
(mpMRI) combined with magnetic resonance (MR)–targeted biopsy to become valuable …
Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging
Background Multiparametric magnetic resonance imaging (mpMRI) undoubtedly affects the
diagnosis and treatment of localized prostate cancer (CaP). However, clinicians need a …
diagnosis and treatment of localized prostate cancer (CaP). However, clinicians need a …
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
Background The prostate-specific antigen (PSA) test is used to screen for prostate cancer
but has a high false-positive rate that translates into unnecessary prostate biopsies and …
but has a high false-positive rate that translates into unnecessary prostate biopsies and …